Tuesday 30 April 2019

Cipla gets USFDA nod for pulmonary arterial hypertension drug

Cipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.

from Stocks-Markets-Economic Times http://bit.ly/2VBkyUm

No comments: